940 related articles for article (PubMed ID: 28013264)
21. Rapid detection of carbapenemase-producing Acinetobacter baumannii and carbapenem-resistant Enterobacteriaceae using a bioluminescence-based phenotypic method.
van Almsick V; Ghebremedhin B; Pfennigwerth N; Ahmad-Nejad P
J Microbiol Methods; 2018 Apr; 147():20-25. PubMed ID: 29427687
[TBL] [Abstract][Full Text] [Related]
22. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
[TBL] [Abstract][Full Text] [Related]
23. Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae.
Castanheira M; Huband MD; Mendes RE; Flamm RK
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652234
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
Wu AY; Chang H; Wang NY; Sun FJ; Liu CP
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1229-1238. PubMed ID: 34824020
[TBL] [Abstract][Full Text] [Related]
27. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
28. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
[TBL] [Abstract][Full Text] [Related]
29. Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
Miller S; Humphries RM
Expert Rev Anti Infect Ther; 2016 Aug; 14(8):705-17. PubMed ID: 27348447
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of carbapenemase genes and plasmid-mediated quinolone resistance determinants in carbapenem-resistant Enterobacteriaceae from five teaching hospitals in central China.
Hu L; Zhong Q; Shang Y; Wang H; Ning C; Li Y; Hang Y; Xiong J; Wang X; Xu Y; Qin Z; Parsons C; Wang L; Yu F
Epidemiol Infect; 2014 Sep; 142(9):1972-7. PubMed ID: 24252194
[TBL] [Abstract][Full Text] [Related]
32. Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.
Saïdani M; Hammami S; Kammoun A; Slim A; Boutiba-Ben Boubaker I
J Med Microbiol; 2012 Dec; 61(Pt 12):1746-1749. PubMed ID: 22918869
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic screening of carbapenemases and associated β-lactamases in carbapenem-resistant Enterobacteriaceae.
Birgy A; Bidet P; Genel N; Doit C; Decré D; Arlet G; Bingen E
J Clin Microbiol; 2012 Apr; 50(4):1295-302. PubMed ID: 22259214
[TBL] [Abstract][Full Text] [Related]
35. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
[TBL] [Abstract][Full Text] [Related]
36. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
Baran I; Aksu N
Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
[TBL] [Abstract][Full Text] [Related]
38. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Logan LK
Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
[TBL] [Abstract][Full Text] [Related]
39. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
[TBL] [Abstract][Full Text] [Related]
40. Carbapenemase-producing Enterobacteriaceae.
Doi Y; Paterson DL
Semin Respir Crit Care Med; 2015 Feb; 36(1):74-84. PubMed ID: 25643272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
